Cargando…

P004 Neglected risk for of invasive candidiasis: s tudy of distribution, species differentiation and antifungal susceptibility pattern of Candidemia among patients with liver disease

POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Patients with liver disease (LD) are more predisposed to candidemia due to the dysfunctional Kupffer cells which fails to capture the circulating yeasts, thereby causing fungal dissemination. Candidemia is ten times more common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Pradeep, Ayyub, Mohd, Kale, Pratibha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510007/ http://dx.doi.org/10.1093/mmy/myac072.P004

Ejemplares similares

P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study
por: Shujanya, Prateek, et al.
Publicado: (2022)

P066 Candidemia in a tertiary care hospital: epidemiology, speciation and antifungal susceptibility pattern
por: M, Rashmi, et al.
Publicado: (2022)

P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India
por: Jain, Vidhi, et al.
Publicado: (2022)

P377 Study of the prevalence of candidemia and its antifungal susceptibility pattern in a tertiary care hospital
por: Sharma, Alisha, et al.
Publicado: (2022)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI)
por: Prattes, Juergen, et al.
Publicado: (2022)

P089 Candidemia: prevalence, species characterization ,and the antibiotic susceptibility profile from a tertiary care hospital in north india
por: William, Ashish, et al.
Publicado: (2022)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

P406 Rise in HIV negative Cryptococcal infection in liver disease patient: epidemiology, risk factor, antifungal susceptibility profile from tertiary care hepatobiliary center
por: Patel, Dhruvi, et al.
Publicado: (2022)

Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia
por: Lindberg, Erika, et al.
Publicado: (2019)

Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran
por: Haghighatfard, Azam, et al.
Publicado: (2022)

P350 Oropharyngeal candidiasis in HIV infected patients: associated risk factors and antifungal susceptibility testing of candida species by disc diffusion method
por: Chaudhary, Pankaj, et al.
Publicado: (2022)

Species Distribution and Antifungal Susceptibility of Invasive Candidiasis: A 2016-2017 Multicenter Surveillance Study in Beijing, China
por: Guo, Li-Na, et al.
Publicado: (2020)

P037 Study of magnitude and risk factors in patients with candidemia at a tertiary care hospital with speciation and antifungal susceptibility of pathogenic Candida isolates.
por: Chauhan, Bhavana, et al.
Publicado: (2022)

P048 Antifungal susceptibility and mechanism of azole resistance in Candida albicans clinical isolates from oropharyngeal candidiasis patients in Iran
por: Jahanshiri, Zahra
Publicado: (2022)

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy
por: Bassetti, Matteo, et al.
Publicado: (2011)

Epidemiology, risk factors, species distribution, and antifungal susceptibility of candidemia among hospitalized patients with COVID-19
por: Kamali Sarvestani, Hasti, et al.
Publicado: (2021)

Epidemiology and antifungal resistance in invasive candidiasis
por: Rodloff, AC, et al.
Publicado: (2011)

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
por: Ma, Chun-fang, et al.
Publicado: (2013)

Invasive candidiasis and candidemia in pediatric and neonatal patients: A review of current guidelines
por: Vasileiou, Eleni, et al.
Publicado: (2018)

Antifungal De-Escalation Is Safe in Critically Ill Patients Treated For Suspected Or Documented Invasive Candidiasis. Data From The Amarcand2 Study
por: Bailly, S, et al.
Publicado: (2015)

P409 Study of epidemiology, risk factors and antifungal sensitivity pattern of fungal pneumonia in critically ill cirrhotics
por: Singh, Paras, et al.
Publicado: (2022)

P141 Study of prevalence, antifungal profile and predictors of mortality in chronic pulmonary Aspergillosis in a cohort of liver disease patient
por: Kale, Pratibha, et al.
Publicado: (2022)

Species Distribution, Antifungal Susceptibility, and Molecular Epidemiology of Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand
por: Boonsilp, Siriphan, et al.
Publicado: (2021)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
por: Gebretekle, Gebremedhin Beedemariam, et al.
Publicado: (2022)

Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China
por: Zeng, Zhang-rui, et al.
Publicado: (2019)

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017)

In vitro antifungal susceptibility pattern of Candida species isolated from gastroesophageal candidiasis
por: Mirshekar, Mohsen, et al.
Publicado: (2021)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis
por: Parslow, Ben Y., et al.
Publicado: (2022)

Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
por: van Prehn, Joffrey, et al.
Publicado: (2017)

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates
por: Mohammadi, R, et al.
Publicado: (2016)

O004 The effect of treating OSA with CPAP on mood and sleepiness
por: Tolson, J, et al.
Publicado: (2023)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
por: Mayandi, Venkatesh, et al.
Publicado: (2023)

808. Outcomes of Invasive Candidiasis Stratified by Antifungal Therapy
por: Box, Maggie, et al.
Publicado: (2023)

P010 Evaluation of antifungal efficacy of two novel cyclic lipopeptides of the class Bacillomycin from Bacillus subtilis RLID 12.1 in a murine model of invasive candidiasis
por: Kashyap, Nisha, et al.
Publicado: (2022)

1284. Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin
por: Thompson, George R, et al.
Publicado: (2020)

Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis
por: Song, You Bum, et al.
Publicado: (2015)

O004. Refractory chronic cluster headache responding absolutely to indomethacin
por: Lisotto, Carlo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_spnre7j4ph8aalldg2htvcvca4